The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
Open accessAbstract
A method is presented for covalently bonding Haemophilus influenzae type b capsular polysaccharide (HIB Ps) to several proteins. The method is efficient and relies upon the use of adipic dihydrazide as a spacer between the capsular polysaccharide and the carrier protein. In contrast to the poor immunogenicity of the purified HIB Ps in mice and rabbits, the HIB Ps-protein conjugates induced serum anti-type b antibodies having bactericidal activity at levels shown to be protective in humans when low doses were injected subcutaneously in a saline solution. The antibody response in mice was related to the dose of the conjugates, increased with the number of injections, and could be primed by the previous injection of the carrier protein. The HIB Ps-protein conjugates were immunogenic in three different mouse strains. The importance of the carrier molecule for the enhanced immunogenicity of the HIB Ps-protein conjugates was shown by the failure of HIB Ps hybrids prepared with either the homologous polysaccharide or pneumococcus type 3 polysaccharide to induce antibodie in mice. Rabbits injected with the HIB Ps-protein conjugates emulsified in Freund's adjuvant produced high levels of serum anti-type b antibodies which induced a bactericidal effect upon H. influenzae type b organisms. It is proposed that the HIB Ps component of the polysaccharide protein conjugates has been converted to a thymic-dependent immunogen. This method may be used to prepare protein-polysaccharide conjugates with HIB Ps and other polysaccharides to be considered for human use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ames, B. N., McCann, J., & Yamasaki, E. (1975) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(75)90046-1 · Cited by 7,381
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
McCann, J., Choi, E., Yamasaki, E., & Ames, B. N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5135 · Cited by 3,323
Chemical Coupling of Peptides and Proteins to Polysaccharides by Means of Cyanogen Halides
AXÉN, R., PORATH, J., & ERNBACK, S. (1967) · Nature · doi:10.1038/2141302a0 · Cited by 2,159
Removal of Fatty Acids from Serum Albumin by Charcoal Treatment
Chen, R. F. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81445-x · Cited by 2,094
VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE
Pittman, M. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.53.4.471 · Cited by 507
Peltola, H., Käythy, H., Sivonen, A., & Mäkelä, P. H. (1977) · Pediatrics · doi:10.1542/peds.60.5.730 · Cited by 498
Inman, J. K., & Dintzis, H. M. (1969) · Biochemistry · doi:10.1021/bi00838a026 · Cited by 461
THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITY
Rajewsky, K., Schirrmacher, V., Nase, S., & Jerne, N. K. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1131 · Cited by 411
The Gamma Globulins: The Antibody Deficiency Syndromes
Rosen, F. S., & Janeway, C. A. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609292751307 · Cited by 407
CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
Avery, O. T., & Goebel, W. F. (1929) · Journal of Experimental Medicine · doi:10.1084/jem.50.4.533 · Cited by 374
Cited by
Peltola, H. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.302-317.2000 · Cited by 1,364
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Graf, J., Iwamoto, Y., Sasaki, M., Martin, G. R., Kleinman, H. K., Robey, F. A., & Yamada, Y. (1987) · Cell · doi:10.1016/0092-8674(87)90707-0 · Cited by 671
Plotkin, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400472111 · Cited by 642
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
Robbins, J. B., Austrian, R., Lee, C. J., Rastogi, S. C., Schiffman, G., Henrichsen, J., Makela, P. H., Broome, C. V., Facklam, R. R., Tiesjema, R. H., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1136 · Cited by 564
Self-citationA Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b
Verez-Bencomo, V., Fernández-Santana, V., Hardy, E., Toledo, M. E., Rodríguez, M. C., Heynngnezz, L., Rodriguez, A., Baly, A., Herrera, L., Izquierdo, M., et al. (2004) · Science · doi:10.1126/science.1095209 · Cited by 495
The Efficacy of a Salmonella typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children
Lin, F. Y. C., Ho, V. A., Khiem, H. B., Trach, D. D., Bay, P. V., Thanh, T. C., Kossaczka, Z., Bryla, D. A., Shiloach, J., Robbins, J. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441701 · Cited by 465
Self-citationStreptococcus pneumoniae: virulence factors, pathogenesis, and vaccines
AlonsoDeVelasco, E., Verheul, A. F. M., Verhoef, J., & Snippe, H. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.4.591-603.1995 · Cited by 390
Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide of Salmonella Typhi
Acharya, I. L., Lowe, C. U., Thapa, R., Gurubacharya, V. L., Shrestha, M. B., Cadoz, M., Schulz, D., Armand, J., Bryla, D. A., Trollfors, B., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710293171801 · Cited by 387
Self-citationRobbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
Self-citationFrosch, M., Görgen, I., Boulnois, G. J., Timmis, K. N., & Bitter-Suermann, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1194 · Cited by 384
Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L. (2011) · Nature Medicine · doi:10.1038/nm.2535 · Cited by 366
Peltola, H., Käyhty, H., Virtanen, M., & Mäkelä, P. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406143102404 · Cited by 349
Peltola, H., Kilpi, T., Anttila, M., Peltola, H., & Kilpi, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92117-x · Cited by 344
Eskola, J., Käyhty, H., Takala, A. K., Peltola, H., Rönnberg, P.-R., Kela, E., Pekkanen, E., McVerry, P. H., & Mäkelä, P. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232004 · Cited by 333
The development of vaccines: how the past led to the future
Plotkin, S. A., & Plotkin, S. L. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2668 · Cited by 333
Accelerating Next-Generation Vaccine Development for Global Disease Prevention
Koff, W. C., Burton, D. R., Johnson, P. R., Walker, B. D., King, C. R., Nabel, G. J., Ahmed, R., Bhan, M. K., & Plotkin, S. A. (2013) · Science · doi:10.1126/science.1232910 · Cited by 282
Glycoconjugate vaccines and immune interference: A review
Dagan, R., Poolman, J., & Siegrist, C.-A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.026 · Cited by 270
Stein, K. E., & Söderström, T. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1001 · Cited by 263
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Pobre, K., Tashani, M., Ridda, I., Rashid, H., Wong, M., & Booy, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.047 · Cited by 76
Metadata
- Authors
- Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1980-08-01
- Volume
- 152
- Issue
- 2
- Pages
- 361-376
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169253475
- Cited by
- 625
- References
- 22
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.